Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuroprotective Effects of the Nutraceutical Dehydrozingerone and Its C2-Symmetric Dimer in a Drosophila Model of Parkinson's Disease.

Biomolecules - 24 Feb 2024

Setzu Maria Dolores, Mocci Ignazia, Fabbri Davide, Carta Paola, Muroni Patrizia, Diana Andrea, Dettori Maria Antonietta, Casu Maria Antonietta

Abstract excerpt

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons responsible for unintended or uncontrollable movements. Mutations in the leucine-rich repeat kinase 2 locus contribute to genetic forms of PD. The fruit fly Drosophila melanogaster carrying this mutation (LRRK2-Dm) is an in vivo model of PD that develops motor impairment and stands for an eligible...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dietary Supplements
Share to Dopaminergic Neurons

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drosophila

Share to Drosophila melanogaster

Share to Mutation

Share to Neuroprotective Agents

Share to Parkinson Disease

Share to Persons with Disabilities

Source

Open in PubMed Open full text

Identifiers

PMID: 38540694
DOI: 10.3390/biom14030273
PMCID: PMC10968126

Genes

C2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neuroprotective Effects of the Nutraceutical Dehydrozingerone and Its C2-Symmetric Dimer in a Drosophila Model of Parkinson's Disease.PMID 38540694Read ↗

Neuroprotective Effects of the Nutraceutical Dehydrozingerone and its C2- symmetric Dimer in a Drosophila Model of Parkinson’s DiseaseSemantic proximity Read ↗

Identification of structural features of selected flavonoids responsible for neuroprotection using a <i>Drosophila</i> model of Parkinson’s diseaseSemantic proximity Read ↗

Ameliorative Role of Nutraceuticals on Neurodegenerative Diseases Using theDrosophila melanogasteras a Discovery Model to Define BioefficacySemantic proximity Read ↗

GardeninA confers neuroprotection against environmental toxin in a Drosophila model of Parkinson’s diseaseSemantic proximity Read ↗

Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson’s diseaseSemantic proximity Read ↗

Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2WD40 Genetic Model of Parkinson’s DiseaseSemantic proximity Read ↗

Neuroprotective Effect of the Marine-Derived Compound 11-Dehydrosinulariolide through DJ-1-Related Pathway in In Vitro and In Vivo Models of Parkinson’s DiseaseSemantic proximity Read ↗

Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models.Semantic proximity Read ↗

Neuroprotective potential of an <i>Ayurvedic</i> compound “Ras-Sindoor” on <i>Drosophila melanogaster</i> model of Parkinson’s diseaseSemantic proximity Read ↗

Molecular insight into the mechanism of action of some beneficial flavonoids for the treatment of Parkinson’s DiseaseSemantic proximity Read ↗

Using Drosophila as a platform for drug discovery from natural products in Parkinson's diseaseSemantic proximity Read ↗

Age specific neuroprotection of curcumin is through differential modulation of brain dopamine metabolism: Insights from Drosophila model of Parkinson’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.